Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Strides Pharma Science Ltd (STAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH33228FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company operates through pharma, branded generic and institutional business segments. It manufactures soft and hard gelatin capsules, tablets, oral liquids, powders, topicals and other generic products. Strides Pharma drugs are used to treat AIDS, tuberculosis, Malaria, leprosy, h1n1, covid-19, hepatitis and other infectious diseases. The company works in collaboration with SUDA Pharmaceuticals Ltd, Medicines Malaria Venture (MMV), Gilead Life Sciences Inc and other organizations to develop its products. It has manufacturing facilities in India, Italy, the US and Singapore. Strides Pharma is headquartered in Bangalore, Karnataka, India.

Strides Pharma Science Ltd Key Recent Developments

Jan 10,2021: Aditya Puri joins global pharma major Strides Group as advisor
Nov 17,2020: New Product Launches to take the Precision Cancer Therapies Market to higher Strides between …
Nov 16,2020: New Product Launches to take the Gynecology Lasers Market to higher Strides between 2020 and …
Oct 31,2020: Strides Pharma to set up 800-mn capacity vaccine suite in Bengaluru
Sep 19,2020: New Product Launches to take the Vitreous Detachment Treatment Market to higher Strides …

This comprehensive SWOT profile of Strides Pharma Science Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Strides Pharma Science Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Strides Pharma Science Ltd – Key Information
Strides Pharma Science Ltd – Overview
Strides Pharma Science Ltd – Key Employees
Strides Pharma Science Ltd – Key Employee Biographies
Strides Pharma Science Ltd – Key Operational Heads
Strides Pharma Science Ltd – Major Products and Services
Strides Pharma Science Ltd – History
Strides Pharma Science Ltd – Company Statement
Strides Pharma Science Ltd – Locations And Subsidiaries
Strides Pharma Science Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Strides Pharma Science Ltd – Business Description
Strides Pharma Science Ltd – Corporate Strategy
Strides Pharma Science Ltd – SWOT Analysis
SWOT Analysis – Overview
Strides Pharma Science Ltd – Strengths
Strides Pharma Science Ltd – Weaknesses
Strides Pharma Science Ltd – Opportunities
Strides Pharma Science Ltd – Threats
Strides Pharma Science Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Strides Pharma Science Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Strides Pharma Science Ltd, Key Information
Strides Pharma Science Ltd, Key Ratios
Strides Pharma Science Ltd, Share Data
Strides Pharma Science Ltd, Major Products and Services
Strides Pharma Science Ltd, History
Strides Pharma Science Ltd, Key Employees
Strides Pharma Science Ltd, Key Employee Biographies
Strides Pharma Science Ltd, Key Operational Heads
Strides Pharma Science Ltd, Other Locations
Strides Pharma Science Ltd, Subsidiaries

Strides Pharma Science Ltd, Key Competitors
Strides Pharma Science Ltd, SWOT Analysis
Strides Pharma Science Ltd, Ratios based on current share price
Strides Pharma Science Ltd, Annual Ratios
Strides Pharma Science Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnos …
  • Xtreme Drilling Corp (XDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Xtreme Drilling Corp (Xtreme Drilling), formerly Xtreme Drilling and Coil Services Corp is an onshore drilling rig service provider for oil and gas service companies. The company's products include coiled tubing units, drilling rigs, variable frequency drive systems, integrated AC top drives …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital’s research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, researc …
  • Origin Energy Ltd (ORG):石油・ガス:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Sojitz Corporation:企業の戦略・SWOT・財務分析
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Technical University of Denmark:製薬・医療:M&Aディール及び事業提携情報
    Summary Technical University of Denmark (DTU) is an educational and research service provider. The university offers undergraduate programs, graduate programs, PhD programs, BSc programs, MSc programs, guest student services, accommodation services and others. It conducts research programs in the ar …
  • BPS Direct LLC:企業の戦略・SWOT・財務分析
    BPS Direct LLC - Strategy, SWOT and Corporate Finance Report Summary BPS Direct LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CFF GmbH & Co KG:戦略・SWOT・企業財務分析
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Monopar Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Monopar Therapeutics Inc (Monopar) is a biopharmaceutical company that develops drugs and drug combinations to improve clinical outcomes for cancer patients. The company’s pipeline product includes huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers incl …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務情報
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Krung Thai Bank PCL:企業の戦略・SWOT・財務分析
    Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report Summary Krung Thai Bank PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • Hrvatski Telekom d.d. (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom d.d. (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • TearScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a si …
  • Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析
    Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆